Ferroptosis and hearing loss: from molecular mechanisms to therapeutic interventions

J Enzyme Inhib Med Chem. 2025 Dec;40(1):2468853. doi: 10.1080/14756366.2025.2468853. Epub 2025 Feb 24.

Abstract

Hearing loss profoundly affects social engagement, mental health, cognition, and brain development, with sensorineural hearing loss (SNHL) being a major concern. Linked to ototoxic medications, ageing, and noise exposure, SNHL presents significant treatment challenges, highlighting the need for effective prevention and regeneration strategies. Ferroptosis, a distinct form of cell death featuring iron-dependent lipid peroxidation, has garnered interest due to its potential role in cancer, ageing, and neuronal degeneration, especially hearing loss. The emerging role of ferroptosis as a crucial mediator in SNHL suggests that it may offer a novel therapeutic target for otoprotection. This review aims to summarise the intricate connection between ferroptosis and SNHL, offering a fresh perspective for exploring targeted therapeutic strategies that could potentially mitigate cochlear cells damage and enhance the quality of life for individuals with hearing impairments.

Keywords: Hearing loss; ferroptosis; otoprotection.

Publication types

  • Review

MeSH terms

  • Animals
  • Ferroptosis* / drug effects
  • Hearing Loss* / drug therapy
  • Hearing Loss* / metabolism
  • Hearing Loss* / pathology
  • Hearing Loss, Sensorineural* / drug therapy
  • Hearing Loss, Sensorineural* / metabolism
  • Hearing Loss, Sensorineural* / pathology
  • Humans